Recent publications on Biostatistics

Liu SH, Bobb JF, Henn BC, Schnaas L, Tellez-Rojo MM, Gennings C, Arora M, Wright RO, Coull BA, Wand MP Modeling the health effects of time-varying complex environmental mixtures: Mean field variational Bayes for lagged kernel machine regression 2018 Jun;29(4). doi: 10.1002/env.2504. Epub 2018-05-18. PubMed

Hopp S, Dominici F, Bobb JF Medical diagnoses of heat wave-related hospital admissions in older adults 2018 May;110:81-85. doi: 10.1016/j.ypmed.2018.02.001. Epub 2018-02-08. PubMed

Chrischilles EA, Gagne JJ, Fireman B, Nelson J, Toh S, Shoaibi A, Reichman ME, Wang S, Nguyen M, Zhang R, Izem R, Goulding MR, Southworth MR, Graham DJ, Fuller C, Katcoff H, Woodworth T, Rogers C, Saliga R, Lin ND, McMahill-Walraven CN, Nair VP, Haynes K, Carnahan RM Prospective surveillance pilot of rivaroxaban safety within the US Food and Drug Administration Sentinel System 2018 Mar;27(3):263-271. doi: 10.1002/pds.4375. Epub 2018-01-10. PubMed

Toh S, Wellman R, Coley RY, Horgan C, Sturtevant J, Moyneur E, Janning C, Pardee R, Coleman KJ, Arterburn D, McTigue K, Anau J, Cook AJ Combining distributed regression and propensity scores: a doubly privacy-protecting analytic method for multicenter research 2018 Jan;10:1773-1786. doi: 10.2147/CLEP.S178163. Epub 2018-11-27. PubMed

Akosile M, Pierce S, Brandt M, Verstovsek S, Borthakur G, Kantarjian H, Ravandi F, Wierda W, Garcia-Manero G, Daver N, Kadia T, Burger JA, Pemmaraju N, Jabbour E, Cortes J. Survival impact of patients (pts) with chronic myeloid leukemia (CML) due to failure from the use of one or more tyrosine kinase inhibitors (TKI). Blood, 126(23), 1587. Accessed December 11, 2017. Retrieved from http://www.bloodjournal.org/content/126/23/1587. PubMed

Herman PM, Anderson ML, Sherman KJ, Balderson BH, Turner JA, Cherkin DC Cost-effectiveness of Mindfulness-based Stress Reduction Versus Cognitive Behavioral Therapy or Usual Care Among Adults With Chronic Low Back Pain 2017 Oct 15;42(20):1511-1520. doi: 10.1097/BRS.0000000000002344. PubMed

Soria JC, Adjei AA, Bahleda R, Besse B, Ferte C, Planchard D, Zhou J, Ware J, Morrissey K, Shankar G, Lin W, Schutzman JL, Dy GK, Groen HJM. A phase IB dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with either paclitaxel and carboplatin or pemetrexed and cisplatin in patients with advanced non-small cell lung cancer. Eur J Cancer. 2017 Nov;86:186-196. doi: 10.1016/j.ejca.2017.08.027. Epub 2017 Oct 6. PubMed

Boddu P, Garcia-Manero G, Ravandi F, Borthakur G, Jabbour E, DiNardo C, Jain N, Daver N, Pemmaraju N, Anderlini P, Parmar S, Kc D, Akosile M, Pierce SA, Champlin R, Cortes J, Kantarjian H, Kadia T. Clinical outcomes in adult patients with aplastic anemia: a single institution experience Am J Hematol. 2017 Dec;92(12):1295-1302. doi: 10.1002/ajh.24897. Epub 2017 Sep 25. PubMed

Leong S, Moss RA, Bowles DW, Ware JA, Zhou J, Spoerke JM, Lackner MR, Shankar G, Schutzman JL, van der Noll R, Voest EE, Schellens JHM. A phase I dose-escalation study of the safety and pharmacokinetics of pictilisib in combination with erlotinib in patients with advanced solid tumors. Oncologist. 2017 Aug 10. pii: theoncologist.2017-0090. doi: 10.1634/theoncologist.2017-0090. [Epub ahead of print]. PubMed

Bobb JF, Lee AK, Lapham GT, Oliver M, Ludman E, Achtmeyer C, Parrish R, Caldeiro RM, Lozano P, Richards JE, Bradley KA Evaluation of a Pilot Implementation to Integrate Alcohol-Related Care within Primary Care 2017 Sep 8;14(9). doi: 10.3390/ijerph14091030. Epub 2017-09-08. PubMed